Balance Labs, Inc.
BLNC
$2.11
-$0.05-2.32%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 57.93% | 116.31% | 233.75% | 216.22% | 180.23% |
| Gross Profit | -57.93% | -116.31% | -233.75% | -4,806.45% | -273.38% |
| SG&A Expenses | 175.42% | 62.82% | 40.53% | -53.80% | -66.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.18% | 95.06% | 133.08% | 19.67% | -2.87% |
| Operating Income | -88.18% | -95.06% | -133.08% | -60.50% | -196.53% |
| Income Before Tax | -11.54% | -1.56% | -38.39% | -20.04% | 20.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.54% | -1.56% | -38.39% | -20.04% | 20.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.54% | -1.56% | -38.39% | -20.04% | 20.65% |
| EBIT | -88.18% | -95.06% | -133.08% | -60.50% | -196.53% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -11.52% | -1.05% | -38.07% | -19.23% | 21.07% |
| Normalized Basic EPS | -38.39% | -39.25% | -46.46% | -17.59% | -33.33% |
| EPS Diluted | -14.42% | 10.28% | -21.50% | -7.51% | 25.09% |
| Normalized Diluted EPS | -38.39% | -39.25% | -46.46% | -17.59% | -33.33% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |